The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amphion Innovations Confident After Motif IPO, 2014 Asset Value Fall

Tue, 23rd Jun 2015 09:28

LONDON (Alliance News) - Amphion Innovations PLC Tuesday posted a decline in net asset value for 2014, hit by a fall in the share price of Kromek Group PLC, but expressed confidence for the coming year on the back of the initial public offering of portfolio company Motif Bio PLC.

Amphion invests and partners with companies in the medical and technologies sectors.

The company had a net asset value per share of USD0.011 at the end of 2014, compared to USD0.10 at the end of 2013. This was primarily due to the fall in the share price of radiation technology firm Kromek, which reduced the value of Amphion's holding in Kromek.

The company said that despite repeated profit warnings since Kromek's initial public offering and its disappointing share price, it continues to believe that Kromek's technology "holds great promise".

Amphion posted a pretax loss of USD10.9 million for 2014, widened from a pretax loss of USD4.9 million, mostly as a result of a USD10.0 million fair value loss on investments. Revenue fell to USD484,700 from USD1.0 million.

Motif Bio listed on AIM in early April, and since then has seen a rise in its share price, which Amphion believes on a pro-forma basis will result in a "massive improvement" in its balance sheet and net asset value.

"As expected, the recovery in the stock market and the IPO market in particular has led to an improvement in the overall climate for our business," the company said in a statement.

"With the transformation in Motif's business, we have been able to take advantage of these improved market conditions and with the sharp rise in the valuation of Motif since the IPO we have been able to approach the equity capital markets again for the first time in over seven years," Amphion added.

Motif Bio said Tuesday it raised GBP22 million in a share placing, following which Amphion's diluted holding in the fellow AIM-list firm will be 29%.

Shares in Amphion are trading down 3.1% at 6.66 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
14 Jun 2021 20:33

TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac

TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac

Read more
26 May 2021 21:28

IN BRIEF: Motif Bio expects market capitalisation of GBP16.2 million

IN BRIEF: Motif Bio expects market capitalisation of GBP16.2 million

Read more
26 May 2021 18:18

TRADING UPDATES: AVI Global sees strong results; Finsbury Food rebound

TRADING UPDATES: AVI Global sees strong results; Finsbury Food rebound

Read more
10 May 2021 15:52

IN BRIEF: Motif Bio 2020 loss narrows due to impairment in prior year

IN BRIEF: Motif Bio 2020 loss narrows due to impairment in prior year

Read more
29 Mar 2021 14:25

IN BRIEF: Motif Bio progresses reverse takeover, expects AIM return

IN BRIEF: Motif Bio progresses reverse takeover, expects AIM return

Read more
26 Feb 2021 20:20

LONDON TRADING UPDATES: Motif Bio Says Orange Avenue Buys Subsidiary

LONDON TRADING UPDATES: Motif Bio Says Orange Avenue Buys Subsidiary

Read more
27 Jan 2021 14:37

IN BRIEF: Motif Bio Making Progress On UK Drug Development Firm Buy

IN BRIEF: Motif Bio Making Progress On UK Drug Development Firm Buy

Read more
5 Jan 2021 15:04

IN BRIEF: Motif Bio Advancing Process To Complete Reverse Takeover

IN BRIEF: Motif Bio Advancing Process To Complete Reverse Takeover

Read more
12 Oct 2020 11:50

Cash Shell Motif Bio Swings To Interim Loss On Derivative Liabilities

Cash Shell Motif Bio Swings To Interim Loss On Derivative Liabilities

Read more
23 Sep 2020 16:13

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Sep 2020 14:08

IN BRIEF: Motif Bio Annual Pretax Loss Narrows Amid Takeover Hopes

IN BRIEF: Motif Bio Annual Pretax Loss Narrows Amid Takeover Hopes

Read more
29 Jul 2020 15:39

IN BRIEF: Motif Bio Shares Suspended; Still Hopes For Reverse Takeover

IN BRIEF: Motif Bio Shares Suspended; Still Hopes For Reverse Takeover

Read more
29 Jul 2020 09:59

Motif Bio shares suspended from trading

(Sharecast News) - Pharmaceutical company Motif Bio saw its shares suspended from trading on Wednesday in order to satisfy AIM rules.

Read more
23 Jun 2020 08:48

CORRECT: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline

CORRECT: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline

Read more
22 Jun 2020 14:14

IN BRIEF: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline

IN BRIEF: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.